Chemoprophylaxis Use Appears Tied To Delayed Symptom Onset In Travelers Who Develop Plasmodium Vivax Or P Ovale Malaria Infections, Study Suggests
September 19, 2022
Infectious Disease Advisor (9/16, Nye) reported “chemoprophylaxis use was found to be associated with delayed symptom onset in patients who developed Plasmodium vivax or P ovale malaria infections after traveling to malaria-endemic countries, according to...